Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Telmisartan Restricts Chikungunya Virus Infection In Vitro and In Vivo through the AT1/PPAR-γ/MAPKs Pathways
Saikat De, Prabhudutta Mamidi, Soumyajit Ghosh, et al.
Antimicrobial Agents and Chemotherapy (2021) Vol. 66, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Drugs targeting structural and nonstructural proteins of the chikungunya virus: A review
Mengke Wang, Lidong Wang, Ping Leng, et al.
International Journal of Biological Macromolecules (2024) Vol. 262, pp. 129949-129949
Closed Access | Times Cited: 12
Peroxisome Proliferator-Activated Receptor-Targeted Therapies: Challenges upon Infectious Diseases
In Soo Kim, Prashanta Silwal, Eun‐Kyeong Jo
Cells (2023) Vol. 12, Iss. 4, pp. 650-650
Open Access | Times Cited: 16
TLR4 is one of the receptors for Chikungunya virus envelope protein E2 and regulates virus induced pro-inflammatory responses in host macrophages
Chandan Mahish, Saikat De, Sanchari Chatterjee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
DNA Damage Response Signaling Is Crucial for Effective Chikungunya Virus Replication
Sanchari Chatterjee, Sameer Kumar, Prabhudutta Mamidi, et al.
Journal of Virology (2022) Vol. 96, Iss. 23
Open Access | Times Cited: 13
In Silico Drug Repurposing Uncovered the Antiviral Potential of the Antiparasitic Drug Oxibendazole Against the Chikungunya Virus
Vitor Won‐Held Rabelo, Maria Leonisa Sanchez-Nuñez, Leonardo S. Corrêa-Amorim, et al.
ACS Omega (2024) Vol. 9, Iss. 25, pp. 27632-27642
Open Access | Times Cited: 2
Chikungunya virus time course infection of human macrophages reveals intracellular signaling pathways relevant to repurposed therapeutics
Madison T. Gray, Israel Guerrero‐Arguero, Antonio Solis‐Leal, et al.
PeerJ (2022) Vol. 10, pp. e13090-e13090
Open Access | Times Cited: 10
Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant
Nirmitee Mulgaonkar, Haoqi Wang, Junrui Zhang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1891-1891
Open Access | Times Cited: 5
MBZM-N-IBT, a Novel Small Molecule, Restricts Chikungunya Virus Infection by Targeting nsP2 Protease Activity In Vitro , In Vivo , and Ex Vivo
Saikat De, Soumyajit Ghosh, Supriya Suman Keshry, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 7
Open Access | Times Cited: 8
Analysis of nutritional value, antiviral potential and in vivo toxicological evaluation of Termitomyces clypeatus R. Hiem mycelial extract, a wild edible mushroom
Joshua Khumlianlal, Jobina Rajkumari, Supriya Suman Keshry, et al.
Food Bioscience (2024) Vol. 61, pp. 104817-104817
Closed Access | Times Cited: 1
Targeting renin–angiotensin system
Bharat Bhusan Subudhi, Pratap Kumar Sahu
Elsevier eBooks (2023), pp. 107-150
Closed Access | Times Cited: 2
Complete genome sequence of an Indian outbreak strain of chikungunya virus
Eshna Laha, Deepak Jena, Viplov Kumar Biswas, et al.
Microbiology Resource Announcements (2024) Vol. 13, Iss. 9
Open Access
Chikungunya virus infection inhibits B16 melanoma-induced immunosuppression of T cells and macrophages mediated by interleukin 10
Somlata Khamaru, Tathagata Mukherjee, Kshyama Subhadarsini Tung, et al.
Microbial Pathogenesis (2024), pp. 107022-107022
Closed Access
Upregulation, Functional Association, and Correlated Expressions of TRPV1 and TRPA1 During Telmisartan-Driven Immunosuppression of T Cells
Tathagata Mukherjee, Kshyama Subhadarsini Tung, Parthasarathi Jena, et al.
Immunological Investigations (2024) Vol. 53, Iss. 4, pp. 622-639
Open Access
Analysis of the anti-PCV2 mechanism of Lactobacillus acidophilus based on non-target metabolomics and high-throughput molecular docking
Zhigang Cao, Xiaoya Ling, Abdul Haseeb, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
Synthesis and evaluation of the activity of 1H-1,2,3-triazole-thiophene ester derivatives against Chikungunya virus
Priscilla O. Esteves, Claudio Cesar Cirne-Santos, Caroline de Souza Barros, et al.
The Microbe (2024), pp. 100220-100220
Open Access
A Comprehensive Molecular and Clinical Investigation of Approved Anti-HCV Drugs Repurposing against SARS-CoV-2 Infection: A Glaring Gap between Benchside and Bedside Medicine
Sneha B. Bansode, Pawan Singh, Meenakshi B. Tellis, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 515-515
Open Access | Times Cited: 1
Conjugates of ibuprofen inhibit CHIKV infection and inflammation
Rudra Narayan Dash, Prabhudutta Mamidi, Saikat De, et al.
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1261-1272
Closed Access | Times Cited: 1
Targeting host factors of virus-induced inflammation: a strategy for tackling future epidemics by RNA viruses
Bharat Bhusan Subudhi, Subhasis Chattopadhyay, Soma Chattopadhyay
Future Virology (2022) Vol. 17, Iss. 4, pp. 201-204
Closed Access | Times Cited: 1
DNA damage response signaling is crucial for effective Chikungunya virus replication
Sanchari Chatterjee, Sameer Kumar, Prabhudutta Mamidi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Identifying repurposed drugs with moderate anti-influenza virus activity through computational prioritization of drug-target pairs
Biruhalem Taye, Roland Thünauer, Richard J. Sugrue, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Salicylic Acid Conjugate of Telmisartan Inhibits Chikungunya Virus Infection and Inflammation
Rudra Narayan Dash, Amrita Ray, Prabhudutta Mamidi, et al.
ACS Omega (2023)
Open Access
Page 1

Scroll to top